Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
More News and Success Stories.
-
19 Jun 2026
See more British company OQC chooses Barcelona to open southern Europe’s largest quantum computing center with more than 200 employeesBritish company OQC chooses Barcelona to open southern Europe’s largest quantum computing center with more than 200 employees
-
17 Jun 2026
See more Swiss robotics company ANYbotics opens a new office in BarcelonaSwiss robotics company ANYbotics opens a new office in Barcelona
-
01 Jun 2026
See more Chinese company COSCO and PTP to invest €116 million in the Port of Tarragona as a strategic logistics gateway to EuropeChinese company COSCO and PTP to invest €116 million in the Port of Tarragona as a strategic logistics gateway to Europe
-
29 May 2026
See more Finnish chemical company Kemira to invest 40M€ in two new plants at its facilities in CataloniaFinnish chemical company Kemira to invest 40M€ in two new plants at its facilities in Catalonia
